Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial

Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
doi: https://doi.org/10.1101/2021.11.20.21266229

Article usage

Article usage: November 2021 to December 2024

AbstractFullPdf
Nov 20211250541207
Dec 20211838380258
Jan 20226126735
Feb 20224182042
Mar 20221791017
Apr 2022100720
May 2022101916
Jun 202285818
Jul 20227616
Aug 202253314
Sep 202255017
Oct 202250617
Nov 202244012
Dec 202238614
Jan 202342823
Feb 202350234
Mar 202337249
Apr 202334215
May 202317215
Jun 202325413
Jul 202313113
Aug 2023231411
Sep 202329510
Oct 202330012
Nov 202322310
Dec 202321012
Jan 202421612
Feb 202422510
Mar 20241818
Apr 2024347221
May 202424211
Jun 202427414
Jul 202443316
Aug 202423214
Sep 202429621
Oct 202418612
Nov 202451328
Dec 202420516
Back to top
Posted November 25, 2021.
Download PDF
Data/Code
Email
Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
medRxiv 2021.11.20.21266229; doi: https://doi.org/10.1101/2021.11.20.21266229
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area